IBU Fundamental Analysis - IBU-TEC ADVANCED MATERIALS A

Fundamental Rating

IBU gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 68 industry peers in the Chemicals industry. No worries on liquidiy or solvency for IBU as it has an excellent financial health rating, but there are worries on the profitability. IBU is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

IBU had negative earnings in the past year.

IBU had a positive operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: IBU reported negative net income in multiple years.

In multiple years IBU reported negative operating cash flow during the last 5 years.

1.2 Ratios

IBU has a worse Return On Assets (-7.69%) than 75.00% of its industry peers.

The Return On Equity of IBU (-10.32%) is worse than 70.59% of its industry peers.

		Industry Rank	Sector Rank
ROA	-7.69%
ROE	-10.32%
ROIC	N/A

ROA(3y)-3.09%

ROA(5y)-1.54%

ROE(3y)-4.18%

ROE(5y)-1.98%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a decent Gross Margin value of 46.34%, IBU is doing good in the industry, outperforming 69.12% of the companies in the same industry.

In the last couple of years the Gross Margin of IBU has declined.

IBU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	46.34%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.97%

GM growth 5Y-1.86%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

IBU does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for IBU remains at a similar level compared to 1 year ago.

Compared to 5 years ago, IBU has more shares outstanding

The debt/assets ratio for IBU has been reduced compared to a year ago.

2.2 Solvency

IBU has an Altman-Z score of 2.56. This is not the best score and indicates that IBU is in the grey zone with still only limited risk for bankruptcy at the moment.

IBU has a better Altman-Z score (2.56) than 66.18% of its industry peers.

The Debt to FCF ratio of IBU is 2.92, which is a good value as it means it would take IBU, 2.92 years of fcf income to pay off all of its debts.

IBU has a Debt to FCF ratio of 2.92. This is amongst the best in the industry. IBU outperforms 88.24% of its industry peers.

IBU has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.

IBU has a Debt to Equity ratio of 0.13. This is amongst the best in the industry. IBU outperforms 80.88% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.13
Debt/FCF	2.92
Altman-Z	2.56

ROIC/WACCN/A

WACC6.81%

2.3 Liquidity

IBU has a Current Ratio of 7.42. This indicates that IBU is financially healthy and has no problem in meeting its short term obligations.

The Current ratio of IBU (7.42) is better than 98.53% of its industry peers.

A Quick Ratio of 2.75 indicates that IBU has no problem at all paying its short term obligations.

IBU has a Quick ratio of 2.75. This is amongst the best in the industry. IBU outperforms 95.59% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	7.42
Quick Ratio	2.75

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

IBU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -113.39%.

The Revenue has been growing slightly by 4.93% in the past year.

Measured over the past years, IBU shows a small growth in Revenue. The Revenue has been growing by 0.88% on average per year.

EPS 1Y (TTM)-113.39%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%24.75%

Revenue 1Y (TTM)4.93%

Revenue growth 3Y4.71%

Revenue growth 5Y0.88%

Sales Q2Q%12.48%

3.2 Future

Based on estimates for the next years, IBU will show a very strong growth in Earnings Per Share. The EPS will grow by 31.58% on average per year.

IBU is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.73% yearly.

EPS Next Y23.88%

EPS Next 2Y31.58%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year8.25%

Revenue Next 2Y14.73%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

IBU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IBU. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

IBU's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. IBU is more expensive than 67.65% of the companies in the same industry.

72.06% of the companies in the same industry are more expensive than IBU, based on the Price/Free Cash Flow ratio.

		Industry Rank	Sector Rank
P/FCF	19.29
EV/EBITDA	50.48

4.3 Compensation for Growth

A more expensive valuation may be justified as IBU's earnings are expected to grow with 31.58% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y31.58%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

IBU has a yearly dividend return of 0.18%, which is pretty low.

IBU's Dividend Yield is slightly below the industry average, which is at 2.96.

Compared to an average S&P500 Dividend Yield of 2.32, IBU's dividend is way lower than the S&P500 average.

		Industry Rank	Sector Rank
Dividend Yield	0.18%

5.2 History

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

DP0%

EPS Next 2Y31.58%

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

IBU-TEC ADVANCED MATERIALS A

FRA:IBU (7/29/2025, 7:00:00 PM)

9.46

-0.12 (-1.25%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)03-25 2025-03-25/amc

Earnings (Next)08-25 2025-08-25

Inst Owners3.82%

Inst Owner ChangeN/A

Ins Owners48.12%

Ins Owner ChangeN/A

Market Cap44.94M

Analysts45.71

Price Target7.75 (-18.08%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0.18%

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)2.7%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.89
P/FCF	19.29
P/OCF	4.82
P/B	0.87
P/tB	0.96
EV/EBITDA	50.48

EPS(TTM)-1.12

EYN/A

EPS(NY)-1.03

Fwd EYN/A

FCF(TTM)0.49

FCFY5.18%

OCF(TTM)1.96

OCFY20.73%

SpS10.66

BVpS10.82

TBVpS9.88

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-7.69%
ROE	-10.32%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	46.34%
FCFM	4.6%

ROA(3y)-3.09%

ROA(5y)-1.54%

ROE(3y)-4.18%

ROE(5y)-1.98%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.97%

GM growth 5Y-1.86%

F-Score4

Asset Turnover0.73

Health

		Industry Rank	Sector Rank
Debt/Equity	0.13
Debt/FCF	2.92
Debt/EBITDA	6.67
Cap/Depr	146.62%
Cap/Sales	13.81%
Interest Coverage	N/A
Cash Conversion	915.14%
Profit Quality	N/A
Current Ratio	7.42
Quick Ratio	2.75
Altman-Z	2.56

F-Score4

WACC6.81%

ROIC/WACCN/A

Cap/Depr(3y)170.7%

Cap/Depr(5y)144.35%

Cap/Sales(3y)15.86%

Cap/Sales(5y)13.92%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-113.39%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%24.75%

EPS Next Y23.88%

EPS Next 2Y31.58%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)4.93%

Revenue growth 3Y4.71%

Revenue growth 5Y0.88%

Sales Q2Q%12.48%

Revenue Next Year8.25%

Revenue Next 2Y14.73%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-108.91%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year183.78%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y147.35%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y286.44%

OCF growth 3YN/A

OCF growth 5Y17.1%

IBU-TEC ADVANCED MATERIALS A (IBU.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens